Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS

NARecruitingINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

October 30, 2023

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Neurogenic BladderMultiple SclerosisOveractive Bladder
Interventions
DEVICE

Magstim Rapid2 System

"The Magstim Rapid2 system is the most commonly used magnetic stimulation system for rTMS clinical studies and therapeutic investigations, capable of selectively inducing, modulating or suppressing neuronal activity. This rTMS device will be used along with the D70 Alpha Coil package, which includes an active coil ideal for focal rTMS and a sham coil, The placebo coil looks identical to its active version and replicates pulse noise without producing the magnetic field necessary to modulate cortical neurons. Additionally, the investigators will be utilizing the StimGuide navigation system (currently available at the HMRI) to accurately target the proposed regions of interest.~The Magstim Rapid2 system is indicated to be used in Multiple Sclerosis patients as target users with lower urinary tract symptoms such as urinary frequency, urinary urgency, urinary incontinence and voiding dysfunction."

Trial Locations (1)

77030

RECRUITING

Houston Methodist Hospital, Houston

All Listed Sponsors
lead

The Methodist Hospital Research Institute

OTHER